Study Conduct

Survey: Patients access to medical records critical to high-quality healthcare

Wednesday, February 22, 2017

In the era of digital health, patients have very high expectations for medical information sharing, but they may not be aware of the healthcare industry’s current limitations. That’s according to a new digital health survey released today by Transcend Insights, a population health management company. The survey found that a vast majority of patients (97%) believe it is important for any health institution, regardless of type or location, to have access to their full medical history in order to receive high-quality care.

[Read More]

Pediatric hematology-oncology initiative launched in Africa

Tuesday, February 21, 2017

His Excellency the President Lieutenant General Dr. Seretse Khama Ian Khama of the Republic of Botswana, the Honorable Minister Dorcas Makgato of the Ministry of Health and Wellness, the Bristol-Myers Squibb Foundation, Texas Children’s Cancer and Hematology Centers (TXCH) and Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children’s Hospital (BIPAI) through public-private partnerships with the governments of Botswana, Uganda and Malawi, announced a $100 million initiative to create an innovative pediatric hematology-oncology treatment network in southern and east Africa. The comprehensive initiative called Global HOPE (Hematology-Oncology Pediatric Excellence) will build long-term capacity to treat and dramatically improve the prognosis of thousands of children with cancer and blood disorders in southern and eastern Africa.

[Read More]

Clinerion and ASUS Life partner in Taiwan

Thursday, February 16, 2017

Clinerion and ASUS Life signed a strategic alliance. Clinerion and ASUS Life, together with the Show Chwan Healthcare System, will deliver innovative services for the efficient running of clinical trials, clinical patient recruitment, market access and real-world evidence in Taiwan.

[Read More]

Study: Quality of randomized control trials not measuring up

Wednesday, February 8, 2017

A majority of healthcare studies are conducted using a randomized control trial (RCT). These trials randomly assign participants into groups who either receive or do not receive treatment. However, until the mid-1990s, some of these studies were falling victim to inadequate reporting, thereby causing confusing and potentially biased results. Reviewing the quality of RCTs in various surgical specialties by using standardized methods is becoming a common practice.

[Read More]

Southern Cancer Center joins The US Oncology Network

Thursday, February 2, 2017

Southern Cancer Center, a physician-owned multi-site medical oncology practice serving the Alabama Gulf Coast region, has joined The US Oncology Network. The Network provides strong and comprehensive practice management capabilities and value-based care expertise that are critical for independent practices such as Southern Cancer Center navigating today’s challenging healthcare landscape. The Network is supported by McKesson Specialty Health, an industry provider of solutions that empower the community patient care delivery system to advance the science, technology and quality of care. Southern Cancer Center and The US Oncology Network share a vision of keeping independent physician groups strong and viable, while aiming to improve patient health.

[Read More]

Charles River Associates acquires C1 Consulting

Wednesday, February 1, 2017

Charles River Associates (CRA), a provider of economic, financial, and management consulting services, has acquired substantially all of the assets of C1 Consulting, a life sciences strategy consulting firm that helps pharmaceutical and biotech clients maximize their business potential through the development of highly tailored commercialization strategies based on advanced analytics, customer insights and therapy area expertise. The newly acquired team will join CRA’s Life Sciences Practice and provide additional breadth, depth, and scale to CRA’s client offerings across the industry. Financial terms of the acquisition were not disclosed. CRA expects the acquisition to be accretive to earnings in fiscal 2017.

[Read More]

Lies and the career research subject

Wednesday, February 1, 2017

Patients can also lie about their health to be accepted into a trial. Some even make their “living” going from one trial to another. The problem will continue, some observers say, until a national registry is put into place to catch these kinds of problems.

[Read More]

Perlara partners with third patient advocacy group

Tuesday, January 31, 2017

Perlara, a global patient portal and drug discovery platform company for the one in 10 families affected by rare disease, has announced the formation of a PerlQuest partnership with Michigan-based Maggie’s PMM2-CDG Cure. PMM2-CDG, formerly known as congenital disorder of glycosylation type 1a, is caused by mutations in the evolutionarily conserved gene PMM2. There are currently no FDA approved treatments for PMM2-CDG.

[Read More]